These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 16386826

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. MDR1 gene polymorphisms and response to acute risperidone treatment.
    Kastelic M, Koprivsek J, Plesnicar BK, Serretti A, Mandelli L, Locatelli I, Grabnar I, Dolzan V.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar 17; 34(2):387-92. PubMed ID: 20060871
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dopamine D2 receptor gene polymorphisms predict well the response to dopamine antagonists at therapeutic dosages in patients with schizophrenia.
    Sakumoto N, Kondo T, Mihara K, Suzuki A, Yasui-Furukori N.
    Psychiatry Clin Neurosci; 2007 Apr 17; 61(2):174-80. PubMed ID: 17362435
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combination of dopamine D2 receptor gene polymorphisms as a possible predictor of treatment-resistance to dopamine antagonists in schizophrenic patients.
    Kondo T, Mihara K, Suzuki A, Yasui-Furukori N, Kaneko S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep 17; 27(6):921-6. PubMed ID: 14499308
    [Abstract] [Full Text] [Related]

  • 7. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
    Sills GJ, Mohanraj R, Butler E, McCrindle S, Collier L, Wilson EA, Brodie MJ.
    Epilepsia; 2005 May 17; 46(5):643-7. PubMed ID: 15857428
    [Abstract] [Full Text] [Related]

  • 8. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
    Yi SY, Hong KS, Lim HS, Chung JY, Oh DS, Kim JR, Jung HR, Cho JY, Yu KS, Jang IJ, Shin SG.
    Clin Pharmacol Ther; 2004 Nov 17; 76(5):418-27. PubMed ID: 15536457
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects.
    Pauli-Magnus C, Feiner J, Brett C, Lin E, Kroetz DL.
    Clin Pharmacol Ther; 2003 Nov 17; 74(5):487-98. PubMed ID: 14586389
    [Abstract] [Full Text] [Related]

  • 12. Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver.
    Owen A, Goldring C, Morgan P, Chadwick D, Park BK, Pirmohamed M.
    Br J Clin Pharmacol; 2005 Mar 17; 59(3):365-70. PubMed ID: 15752383
    [Abstract] [Full Text] [Related]

  • 13. Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypes.
    Yasui-Furukori N, Mihara K, Takahata T, Suzuki A, Nakagami T, De Vries R, Tateishi T, Kondo T, Kaneko S.
    Br J Clin Pharmacol; 2004 May 17; 57(5):569-75. PubMed ID: 15089809
    [Abstract] [Full Text] [Related]

  • 14. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.
    Dolzan V, Serretti A, Mandelli L, Koprivsek J, Kastelic M, Plesnicar BK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug 01; 32(6):1562-6. PubMed ID: 18573584
    [Abstract] [Full Text] [Related]

  • 15. The impact of pharmacogenomic factors on acute persistent rejection in adult lung transplant patients.
    Zheng HX, Zeevi A, McCurry K, Schuetz E, Webber S, Ristich J, Zhang J, Iacono A, Dauber J, McDade K, Zaldonis D, Lamba J, Burckart GJ.
    Transpl Immunol; 2005 Mar 01; 14(1):37-42. PubMed ID: 15814280
    [Abstract] [Full Text] [Related]

  • 16. MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression.
    Mihaljevic Peles A, Bozina N, Sagud M, Rojnic Kuzman M, Lovric M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug 01; 32(6):1439-44. PubMed ID: 18550244
    [Abstract] [Full Text] [Related]

  • 17. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S, Yaren A, Kursunluoglu R, Turgut G.
    Arch Med Res; 2007 Jul 01; 38(5):539-44. PubMed ID: 17560460
    [Abstract] [Full Text] [Related]

  • 18. Association between TaqI A dopamine D2 receptor polymorphism and therapeutic response to bromperidol: a preliminary report.
    Suzuki A, Kondo T, Mihara K, Yasui-Furukori N, Otani K, Furukori H, Kaneko S, Inoue Y.
    Eur Arch Psychiatry Clin Neurosci; 2001 Jul 01; 251(2):57-9. PubMed ID: 11407439
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical response to risperidone in relation to plasma drug concentrations in acutely exacerbated schizophrenic patients.
    Yasui-Furukori N, Saito M, Nakagami T, Furukori H, Suzuki A, Kondo T, Kaneko S.
    J Psychopharmacol; 2010 Jul 01; 24(7):987-94. PubMed ID: 19477882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.